Get started
Author

Kazutaka Miyadera

Observed names: K Miyadera, K. Miyadera
ORCID: 0009-0003-4284-9803
Observed ORCID: 0009-0003-4284-9803
OpenAlex ID: A5063302620
Clinicopathologic and Prognostic Significance of an Angiogenic Factor, Thymidine Phosphorylase, in Human Colorectal Carcinoma
1996 · Y. Takebayashi, S.-i. Akiyama, et al. · JNCI Journal of the National Cancer Institute · 364
Angiogenic activity of enzymes
1994 · Misako Haraguchi, Kazutaka Miyadera, et al. · Nature · 349
The activity and expression of thymidine phosphorylase in human solid tumours
1996 · Y. Takebayashi, K. Yamada, et al. · European Journal of Cancer · 182
Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.
1995 · K Miyadera, T Sumizawa, et al. · PubMed · 182
UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
1999 · K Yonekura, Y Basaki, et al. · PubMed · 113
Prevention of Hypoxia-Induced Apoptosis by the Angiogenic Factor Thymidine Phosphorylase
1998 · Masaki Kitazono, Yuji Takebayashi, et al. · Biochemical and Biophysical Research Communications · 111
Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma.
1997 · Y Imazano, Y Takebayashi, et al. · Journal of Clinical Oncology · 105
Expression of Thymidine Phosphorylase in Human Gastric Carcinoma
1996 · Yuji Takebayashi, Kazutaka Miyadera, et al. · Japanese Journal of Cancer Research · 101
TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations
2018 · Shinichi Hasako, Miki Terasaka, et al. · Molecular Cancer Therapeutics · 87
TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations
2019 · Hibiki Udagawa, Shinichi Hasako, et al. · Molecular Cancer Research · 76
Suppression of metastasis by thymidine phosphorylase inhibitor.
2000 · S Takao, S I Akiyama, et al. · PubMed · 68
γ-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor
2001 · Yuji Basaki, Lumi Chikahisa, et al. · Angiogenesis · 67
Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas.
1998 · S Takao, Y Takebayashi, et al. · PubMed · 61
Targeted Deletion of Both Thymidine Phosphorylase and Uridine Phosphorylase and Consequent Disorders in Mice
2002 · Misako Haraguchi, Hiroaki Tsujimoto, et al. · Molecular and Cellular Biology · 60
Thymidine phosphorylase in human esophageal squamous cell carcinoma
1999 · Yuji Takebayashi, Shoji Natsugoe, et al. · Cancer · 54
PDF
Identification of Substrate Sequences for Membrane Type-1 Matrix Metalloproteinase Using Bacteriophage Peptide Display Library
1999 · Shuichi Ohkubo, Kazutaka Miyadera, et al. · Biochemical and Biophysical Research Communications · 51
The Novel VEGF Receptor/MET–Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Profile
2013 · Hidenori Fujita, Kazutaka Miyadera, et al. · Molecular Cancer Therapeutics · 38
The correlation of thymidine phosphorylase activity with the expression of interleukin 1α, interferon α and interferon γ in human colorectal carcinoma
1995 · Yuji Takebayashi, Kazutaka Yamada, et al. · Cancer Letters · 26
Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics
1999 · Tatsuya Fukuiwa, Yuji Takebayashi, et al. · Cancer · 25
PDF
Substrate Phage as a Tool to Identify Novel Substrate Sequences of Proteases
2001 · Shuichi Ohkubo, Kazutaka Miyadera, et al. · Combinatorial Chemistry & High Throughput Screening · 24
The expression of thymidine phosphorylase/platelet‐derived endothelial cell growth factor is correlated to angiogenesis in breast cancer
1998 · Fumiyo Yonenaga, Takashi Takasaki, et al. · Pathology International · 16
Structural Characterization of Thymidine Phosphorylase Purified from Human Placenta
1995 · K. Miyadera, N. Dohmae, et al. · Biochemical and Biophysical Research Communications · 16
TAS-121, A Selective Mutant EGFR Inhibitor, Shows Activity Against Tumors Expressing Various EGFR Mutations Including T790M and Uncommon Mutations G719X
2019 · Kimihiro Ito, Makoto Nishio, et al. · Molecular Cancer Therapeutics · 12
UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
2000 · Y Basaki, K Aoyagi, et al. · PubMed · 12
Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics
2000 · T. Fukuiwa, Y. Takebayashi, et al. · International Journal of Oral and Maxillofacial Surgery · 10
Works count: 86
Citation count: 2,287
H-index: 20
I10-index: 25
Year
Topic
Type